| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.6M | +2157.9% |
| Cost of Revenue | $13.1M | +4783.6% |
| Gross Profit | $6.5M | +983.1% |
| R&D Expense | $89K | +74.5% |
| SG&A Expense | $8.4M | +99.9% |
| Operating Income | -$3.7M | -697.2% |
| Pre-tax Income | -$14.4M | -498.7% |
| Net Income | -$14.4M | -498.6% |
| EPS (Basic) | -$1.70 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.4M | -63.8% |
| Accounts Receivable | $4.4M | +1397.6% |
| Inventory | $81K | +55.8% |
| Current Assets | $9.5M | -5.5% |
| Total Assets | $20.8M | -4.3% |
| Current Liabilities | $5.4M | +1106.4% |
| Long-term Debt | $1.4M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | +21.6% |
| Capital Expenditures | $12K | +0.0% |
| Investing Cash Flow | -$7.9M | -176.5% |
| Financing Cash Flow | $4.4M | -41.7% |
| Free Cash Flow | -$2.6M | +21.5% |
| -433.3% |
| EPS (Diluted) | -$1.70 | -446.9% |
| Total Liabilities |
| $7.2M |
| +1275.4% |
| Stockholders' Equity | $13.6M | -35.8% |